MIGKX
Price
$45.08
Change
-$0.26 (-0.57%)
Updated
Sep 5 closing price
Net Assets
12.01B
RGEBX
Price
$82.44
Change
+$0.19 (+0.23%)
Updated
Sep 5 closing price
Net Assets
331.65B
Interact to see
Advertisement

MIGKX vs RGEBX

Header iconMIGKX vs RGEBX Comparison
Open Charts MIGKX vs RGEBXBanner chart's image
MFS Massachusetts Inv Gr Stk R4
Price$45.08
Change-$0.26 (-0.57%)
VolumeN/A
Net Assets12.01B
American Funds Growth Fund of Amer R2E
Price$82.44
Change+$0.19 (+0.23%)
VolumeN/A
Net Assets331.65B
MIGKX vs RGEBX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
MIGKX vs. RGEBX commentary
Sep 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MIGKX is a Buy and RGEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 332B vs. MIGKX (12B). MIGKX pays higher dividends than RGEBX: MIGKX (0.41) vs RGEBX (0.00). MIGKX was incepted earlier than RGEBX: MIGKX (20 years) vs RGEBX (11 years). RGEBX (1.09) is less costly to investors than MIGKX (0.46). RGEBX is a more actively managed with annual turnover of: 25.00 vs. MIGKX (19.00). MIGKX has a lower initial minimum investment than RGEBX: MIGKX (0) vs RGEBX (250). RGEBX annual gain was more profitable for investors over the last year : 17.59 vs. MIGKX (1.49). RGEBX return over 5 years is better than : 38.71 vs. MIGKX (26.76).
MIGKXRGEBXMIGKX / RGEBX
Total Expense Ratio0.461.0942%
Annual Report Gross Expense Ratio0.461.0942%
Fund Existence20 years11 years-
Gain YTD5.64815.39837%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets12B332B4%
Annual Yield % from dividends0.410.00-
Returns for 1 year1.4917.598%
Returns for 3 years30.8557.6154%
Returns for 5 years26.7638.7169%
Returns for 10 years102.5491.44112%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ARTV3.610.50
+16.08%
Artiva Biotherapeutics Inc
ARCT17.851.09
+6.50%
Arcturus Therapeutics Holdings
MANH215.315.45
+2.60%
Manhattan Associates
TRMD23.020.25
+1.10%
TORM plc
INDP3.30-1.31
-28.35%
Indaptus Therapeutics Inc